Giant primary intracranial multi-fossa leiomyosarcoma involving the frontal sinus, ethmoid air cells, anterior fossa, middle fossa, and intraventricular space: A case report and literature review.

Anterior fossa Ethmoid air cells Frontal sinus Leiomyosarcoma Middle fossa Transbasal approach

Journal

Surgical neurology international
ISSN: 2229-5097
Titre abrégé: Surg Neurol Int
Pays: United States
ID NLM: 101535836

Informations de publication

Date de publication:
2023
Historique:
received: 03 08 2023
accepted: 11 10 2023
medline: 9 11 2023
pubmed: 9 11 2023
entrez: 9 11 2023
Statut: epublish

Résumé

Leiomyosarcomas (LMSs) is a type of sarcoma that arises from smooth muscle and generally presents in the abdomen. Although intracranial LMS has been identified before, most reported presentations have been in immunocompromised patients. Here, we present an intracranial LMS in an immunocompetent patient. A 22-year-old male with a history of an atypical pineal parenchymal tumor of intermediate differentiation resected by suboccipital craniotomy at the age of 12 followed by adjuvant radiation therapy, presented with 3 weeks of decreased appetite, weight loss, and lethargy. He subsequently underwent transbasal approach skull base tumor resection. Histologic examination of the mass along with the patient's history of radiation was supportive of a low-grade, radiation-induced LMS arising from the anterior fossa of the skull or meninges and extends to the frontal sinus and ethmoid air cells. Primary intracranial LMS is an extremely rare diagnosis and presenting symptoms vary with the location and size of the tumor. Due to the poor specificity of clinical symptoms, diagnosis is often based on histology. The most common treatment is surgical resection. Adjuvant chemotherapy with various agents has been found to be somewhat effective outside the central nervous system. When LMS does occur, a history of immunocompromised state or previous radiation exposure is often present. Pathological confirmation is required for an appropriate diagnosis.

Sections du résumé

Background UNASSIGNED
Leiomyosarcomas (LMSs) is a type of sarcoma that arises from smooth muscle and generally presents in the abdomen. Although intracranial LMS has been identified before, most reported presentations have been in immunocompromised patients. Here, we present an intracranial LMS in an immunocompetent patient.
Case Description UNASSIGNED
A 22-year-old male with a history of an atypical pineal parenchymal tumor of intermediate differentiation resected by suboccipital craniotomy at the age of 12 followed by adjuvant radiation therapy, presented with 3 weeks of decreased appetite, weight loss, and lethargy. He subsequently underwent transbasal approach skull base tumor resection. Histologic examination of the mass along with the patient's history of radiation was supportive of a low-grade, radiation-induced LMS arising from the anterior fossa of the skull or meninges and extends to the frontal sinus and ethmoid air cells.
Conclusion UNASSIGNED
Primary intracranial LMS is an extremely rare diagnosis and presenting symptoms vary with the location and size of the tumor. Due to the poor specificity of clinical symptoms, diagnosis is often based on histology. The most common treatment is surgical resection. Adjuvant chemotherapy with various agents has been found to be somewhat effective outside the central nervous system. When LMS does occur, a history of immunocompromised state or previous radiation exposure is often present. Pathological confirmation is required for an appropriate diagnosis.

Identifiants

pubmed: 37941634
doi: 10.25259/SNI_647_2023
pii: 10.25259/SNI_647_2023
pmc: PMC10629320
doi:

Types de publication

Case Reports

Langues

eng

Pagination

384

Informations de copyright

Copyright: © 2023 Surgical Neurology International.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Onkologie. 2012;35(10):609-16
pubmed: 23038237
Clin Neuropathol. 1995 Jul-Aug;14(4):245-8
pubmed: 8521631
Childs Nerv Syst. 2009 Aug;25(8):1013-7
pubmed: 19308428
J Clin Oncol. 2011 May 10;29(14):e407-10
pubmed: 21357779
Stem Cells. 2017 Jun;35(6):1446-1460
pubmed: 28316123
J Neurosurg. 2013 Aug;119(2):499-503
pubmed: 23621602
Hematol Oncol Clin North Am. 2013 Oct;27(5):957-74
pubmed: 24093170
Neuroradiology. 1999 Jan;41(1):35-9
pubmed: 9987766
Future Microbiol. 2010 Jul;5(7):1025-39
pubmed: 20632803
NMC Case Rep J. 2017 Dec 07;5(1):1-7
pubmed: 29354331
Neurosurgery. 1999 Jan;44(1):199-202
pubmed: 9894982
Cureus. 2020 Jan 23;12(1):e6758
pubmed: 32140326
Zhonghua Zhong Liu Za Zhi. 1987 Nov;9(6):463-4, 22
pubmed: 3452545
Arch Iran Med. 2013 Oct;16(10):606-7
pubmed: 24093144
Front Oncol. 2021 May 20;11:642683
pubmed: 34094927
Clin Neurol Neurosurg. 2018 Feb;165:76-80
pubmed: 29324399
Surg Neurol Int. 2017 Nov 20;8:278
pubmed: 29279795
J Neurosurg. 1980 Sep;53(3):401-5
pubmed: 7420156
Oncology. 2000 Apr;58(3):210-4
pubmed: 10765122
Int J Clin Oncol. 2011 Feb;16(1):63-6
pubmed: 20676716
BMJ Case Rep. 2018 Sep 15;2018:
pubmed: 30219779
J Neurooncol. 1998 Nov;40(2):179-83
pubmed: 9892100
Sarcoma. 2006;2006:52140
pubmed: 17496995
Pediatr Radiol. 2004 Jun;34(6):495-8
pubmed: 15057493
J Neurooncol. 2011 Jul;103(3):785-90
pubmed: 21063896
Hum Pathol. 1998 Mar;29(3):240-5
pubmed: 9496826
J Clin Oncol. 2018 Jan 10;36(2):144-150
pubmed: 29220301
J Inflamm Res. 2022 Jan 26;15:573-593
pubmed: 35115806
J Neurosurg. 1989 Aug;71(2):279-82
pubmed: 2746352
Am J Surg Pathol. 2002 Aug;26(8):1056-63
pubmed: 12170093
Cytokine. 2021 Dec;148:155706
pubmed: 34583254
Ultrastruct Pathol. 1997 May-Jun;21(3):301-5
pubmed: 9183831
J Neurosurg Case Lessons. 2023 Jan 23;5(4):
pubmed: 36692065
World Neurosurg. 2018 Aug;116:169-173
pubmed: 29753901
J Oncol Pract. 2016 Sep;12(9):827-9
pubmed: 27554524
Indian J Surg Oncol. 2020 Sep;11(Suppl 2):165-169
pubmed: 33364689
Clin Neurol Neurosurg. 1997 Aug;99(3):210-2
pubmed: 9350403
Neurosurg Rev. 2021 Aug;44(4):2319-2328
pubmed: 33099713
Radiat Oncol J. 2020 Dec;38(4):282-286
pubmed: 33389983
Clin Neuropathol. 2011 May-Jun;30(3):154-7
pubmed: 21545778
Br J Neurosurg. 2023 Aug;37(4):668-670
pubmed: 30636462
Childs Nerv Syst. 2014 Sep;30(9):1613-6
pubmed: 24752708
J Neurosurg. 1988 Feb;68(2):308-11
pubmed: 3339450

Auteurs

Hannah Choi (H)

Department of Neurosurgery, Loma Linda University Medical School, Loma Linda, California, United States.

Jorrdan N R Bissell (JNR)

Department of Neurosurgery, Loma Linda University Medical School, Loma Linda, California, United States.

Brandon Michael Edelbach (BM)

Department of Neurosurgery, Loma Linda University Medical School, Loma Linda, California, United States.

Joel Paea (J)

Department of Neurosurgery, Loma Linda University Medical School, Loma Linda, California, United States.

Emmanuel Omosor (E)

Department of Neurosurgery, Loma Linda University Medical School, Loma Linda, California, United States.

Ravi Raghavan (R)

Department of Neurosurgery, Loma Linda University Medical School, Loma Linda, California, United States.

Vadim Gospodarev (V)

Department of Neurosurgery, Loma Linda University Medical Center, Loma Linda, California, United States.

Miguel Angel Lopez-Gonzalez (MA)

Department of Neurosurgery, Loma Linda University Medical Center, Loma Linda, California, United States.

Classifications MeSH